Am J Cardiol

1. MORTADA I, Lee A, Sahu A, Nwaogu C, et al
   Additive Cardiorenal Benefits of Finerenone and SGLT2 Inhibitor Combination Therapy in Diabetic CKD: A Propensity-Matched Real-World Study.
   Am J Cardiol. 2026 Feb 27:S0002-9149(26)00089.
   

   >> Share

   
   

   
   BMC Ophthalmol

2. DEMIR K, Celik E
   Comparative outcomes of posterior sub-Tenon triamcinolone for pseudophakic cystoid macular edema in diabetic and non-diabetic patients: a retrospective study.
   BMC Ophthalmol. 2026 Mar 5. doi: 10.1186/s12886-026-04694.
   

   >> Share

   
   

   
   BMJ

3. CAI M, Choi T, Xie Y, Al-Aly Z, et al
   Glucagon-like peptide-1 receptor agonists and risk of substance use disorders among US veterans with type 2 diabetes: cohort study.
   BMJ. 2026;392:e086886.
   

   >> Share

   
   

   
   Circulation

4. ZHANG Z, Zhu D, Liu C, Gan L, et al
   Small Extracellular Vesicle External Surface Adiponectin-Mediated Adipocytes/Cardiomyocytes Communication in Diabetic Ischemic Heart Failure.
   Circulation. 2026 Mar 2. doi: 10.1161/CIRCULATIONAHA.125.076372.
   

   >> Share

   
   

   
   Diabet Med

5. BIAN X, Sun X, Meng L
   Associations of biochemical and metabolic markers with pregnancy outcomes in women with and without gestational diabetes mellitus: A prospective cohort study in eastern China.
   Diabet Med. 2026 Feb 28:e70268. doi: 10.1111/dme.70268.
   

   >> Share

   
   

   
   Diabetes

6. LI Y, Zeng Y, Lian Y, Zhang C, et al
   Unraveling Diabetic Cardiomyopathy (DCM): The Critical Role of the Yap-miR-22-3p-Sirt1 Axis in the Pathogenesis of DCM.
   Diabetes. 2026 Mar 2:db250435. doi: 10.2337/db25-0435.
   

   >> Share

   
   

   
   Diabetes Care

7. CHEHAB RF, Greenberg MB, Lee C, Ngo AL, et al
   Gestational Diabetes, Glycemic Management Trajectories, and Offspring Growth Patterns and Obesity Risk.
   Diabetes Care. 2026 Mar 4:dc251643. doi: 10.2337/dc25-1643.
   

   >> Share

   
   
8. OSTROMINSKI JW, Ortega-Montiel J, Wexler DJ, Everett BM, et al
   Comparative Effectiveness of Tirzepatide Versus Dulaglutide or Semaglutide on Major Cardiovascular Events in Type 2 Diabetes and Cardiovascular Disease: Insights From Two Target-Trial Emulations.
   Diabetes Care. 2026 Mar 4:dc253063. doi: 10.2337/dc25-3063.
   

   >> Share

   
   
9. MITAL S, Schatz DA, Haller MJ, Wherrett DK, et al
   Everyone or Just Some? Cost-Effectiveness of General Population Versus Targeted Screening Strategies for Type 1 Diabetes in Canada.
   Diabetes Care. 2026 Mar 2:dc252248. doi: 10.2337/dc25-2248.
   

   >> Share

   
   

   
   Diabetes Obes Metab

10. TOKGOZ S, Boss M, Meijer RI, Jansen TJP, et al
    Sex Differences in [(68)Ga]Ga-NODAGA-Exendin-4 Uptake in the Pituitary of Individuals With Type 2 Diabetes.
    Diabetes Obes Metab. 2026 Mar 2. doi: 10.1111/dom.70600.
    

    >> Share

    
    
11. ENG PC, Tag WY, Sivaramasubramaniam S, Aung AT, et al
    Pre-Existing Diabetes and Prediabetes in Pregnancy: Evaluation on Glycaemic Control, Pregnancy Outcomes and Clinical Gaps.
    Diabetes Obes Metab. 2026 Mar 2. doi: 10.1111/dom.70619.
    

    >> Share

    
    
12. BONIFACIO E, Scholz M, Weiss A, Ziegler AG, et al
    Comparison of IA-2 Bridge ELISA and Radiobinding Assays for Progression Risk Assessment in Early-Stage Type 1 Diabetes.
    Diabetes Obes Metab. 2026 Mar 3. doi: 10.1111/dom.70630.
    

    >> Share

    
    
13. ZHANG Y, Ji JL, Yao DD, Zhou Y, et al
    Oxaloacetate Restores HIF-1alpha-Mediated Mitochondrial Homeostasis to Counter Tubulointerstitial Injury in Diabetic Kidney Disease.
    Diabetes Obes Metab. 2026 Mar 3. doi: 10.1111/dom.70612.
    

    >> Share

    
    

    
    Diabetologia

14. BALDWIN FD, Bedair KF, Jorgensen AL, Green L, et al
    Identification of a genetic risk factor for metformin-induced vitamin B(12) deficiency.
    Diabetologia. 2026;69:953-965.
    

    >> Share

    
    
15. DANGARDT F, Forsander G, Bergdahl E
    Beyond BMI: the need for improved adiposity assessment in studying subclinical cardiovascular autonomic neuropathy in children with type 1 diabetes. Reply to Risi R, Buzzetti R, Maddaloni E [letter].
    Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06699.
    

    >> Share

    
    
16. KATTE JC, Bavuma C, Wild SH, Hawkins M, et al
    Atypical diabetes subtypes in Black African populations.
    Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06697.
    

    >> Share

    
    
17. MA G, Wu W, Duan Y, Yang Y, et al
    A diabetes-induced change of MDM2 SNP309T-->G contributes to aberrant retinal angiogenesis.
    Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06695.
    

    G contributes to aberrant retinal angiogenesis.&body=MA G, Wu W, Duan Y, Yang Y, et al. A diabetes-induced change of MDM2 SNP309T-->G contributes to aberrant retinal angiogenesis. Diabetologia. 2026 Mar 2. doi: 10.1007/s00125-026-06695. https://pubmed.ncbi.nlm.nih.gov/41770245" ALT="Email" TITLE="Email"> --> >> Share

    
    
18. PHUAH P, Norton M, Cheng S, Roberts AG, et al
    The microbial tryptophan metabolite indole acts on the gastrointestinal tract to improve glucose homeostasis in a mouse model of diabetes by enhancing GLP-1 secretion and L cell differentiation.
    Diabetologia. 2026 Mar 4. doi: 10.1007/s00125-026-06688.
    

    >> Share

    
    

    
    Invest Ophthalmol Vis Sci

19. CHEN TR, Zhou JX, Hou YR, Zhang YN, et al
    Neddylation-Mediated hnRNPA2B1 Degradation Aggravates Retinal Endothelial Cell Dysfunction in Diabetic Retinopathy by Regulating miR-93-5p/VEGFA.
    Invest Ophthalmol Vis Sci. 2026;67:5.
    

    >> Share

    
    

    
    J Am Soc Nephrol

20. HU H, Liang W, Ding G
    Podocyte Metabolic Reprogramming and Targeted Therapy.
    J Am Soc Nephrol. 2026;37:619-633.
    

    >> Share

    
    

    
    J Clin Endocrinol Metab

21. ZHOU X, Carrasquilla GD, Christiansen MR, Smit RAJ, et al
    Association of genetic risk and physical activity with incident type 2 diabetes.
    J Clin Endocrinol Metab. 2026 Feb 27:dgag083. doi: 10.1210.
    

    >> Share

    
    

    
    J Clin Invest

22. GUO C, Sodhi A
    Molecular stress and neurovascular injury in the diabetic retina.
    J Clin Invest. 2026;136:e200945.
    

    >> Share

    
    

    
    J Diabetes Complications

23. AO P, Yuan W, Ma Y, Tian H, et al
    Sarcopenia increases the odds of frailty in older hospitalized diabetic patients.
    J Diabetes Complications. 2026;40:109307.
    

    >> Share

    
    
24. TREVINO MONTEMAYOR M, Ackerer A, Lacroix A, Collet TH, et al
    Sleep and eating patterns in individuals with gestational diabetes: associations with daily overnight and morning glucose using continuous glucose monitoring.
    J Diabetes Complications. 2026;40:109293.
    

    >> Share

    
    
25. ALDAFAS R, Vinogradova Y, Crabtree TSJ, Gordon J, et al
    The long-term impact of early HbA1c control on nephropathy, neuropathy, and retinopathy in type 2 diabetes: Findings from a large UK observational study.
    J Diabetes Complications. 2026;40:109292.
    

    >> Share

    
    

    
    J Immunol

26. ZHANG M, Zeng Y, Li X, Deng N, et al
    Type 2 diabetes impairs macrophage antimicrobial capability and increases susceptibility to sepsis.
    J Immunol. 2026;215:vkaf375.
    

    >> Share

    
    
27. AMDARE N, Ali R, Manganaro A, Baker JC, et al
    Islet-derived T cells from both mice and humans recognize conserved insulin A-chain peptides presented by HLA-C*03:04.
    J Immunol. 2026;215:vkaf381.
    

    >> Share

    
    
28. CHEN J, Fu L, Gong Y, Liao L, et al
    IFNgamma/JAK/STAT1/CD38 pathway in SH2D1Bhigh NK cells: Implications for inflammation in type 1 diabetes.
    J Immunol. 2026;215:vkaf347.
    

    >> Share

    
    

    
    Kidney Int

29. GESUALDO L, Kretzler M, Pontrelli P
    Deep endotyping of renal damage in type 2 diabetes: ex uno, plures.
    Kidney Int. 2026 Feb 27:S0085-2538(26)00143-2. doi: 10.1016/j.kint.2026.
    

    >> Share

    
    

    
    Lancet

30. NAUCK MA, Tuttle KR, Tschop MH, Bluher M, et al
    Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits.
    Lancet. 2026 Jan 14:S0140-6736(25)02105-1. doi: 10.1016/S0140-6736(25)02105.
    

    >> Share

    
    
31. ROSENSTOCK J, Yabe D, Cox D, Li J, et al
    Efficacy and safety of once-daily oral orforglipron compared with oral semaglutide in adults with type 2 diabetes (ACHIEVE-3): a multinational, multicentre, non-inferiority, open-label, randomised, phase 3 trial.
    Lancet. 2026 Feb 26:S0140-6736(26)00202-3. doi: 10.1016/S0140-6736(26)00202.
    

    >> Share

    
    

    
    N Engl J Med

32. HEERSPINK HJL, Birkenfeld AL, Cherney DZI, Colhoun HM, et al
    Finerenone in Type 1 Diabetes and Chronic Kidney Disease.
    N Engl J Med. 2026;394:947-957.
    

    >> Share

    
    
33. KUKLA A, Hogan MC
    Finerenone for Diabetic Kidney Disease in Type 1 Diabetes - A Fine Answer?
    N Engl J Med. 2026;394:1019-1020.
    

    >> Share

    
    

    
    Pediatr Diabetes

34. KIM S, Kim SJ, Cho KW, Song K, et al
    Long-Term Growth Outcomes of Children With Type 1 Diabetes According to Glycemic Control and Use of Continuous Glucose Monitoring: A Retrospective Cohort Study.
    Pediatr Diabetes. 2026;2026:9111583.
    

    >> Share

    
    
35. ALSAGHEIR A, Bin-Abbas B, Alsagheir R, Alhuthil R, et al
    Real-World Experience With Control-IQ Technology in Saudi Children With Insulin-Dependent Diabetes: A Single-Center Observational Study.
    Pediatr Diabetes. 2026;2026:6113065.
    

    >> Share

    
    

    
    Pediatrics

36. CHU PY, Kelly A, Hennessy S, Vajravelu ME, et al
    GLP-1RA Dispensing in Youth With Type 2 Diabetes: 2020 to 2023.
    Pediatrics. 2026 Mar 2:e2025071971. doi: 10.1542/peds.2025-071971.
    

    >> Share

    
    
37. WHOOTEN R, Allen L, Stanford FC
    Disparities in Medication Treatment of Type 2 Diabetes and Obesity.
    Pediatrics. 2026 Mar 2:e2025074840. doi: 10.1542/peds.2025-074840.
    

    >> Share

    
    

    
    PLoS One

38. JAVED S, Javed U, Mohamed Noor DA, Hanafiah NHM, et al
    Glycemic trajectories of fasting blood glucose on the pathological responses in breast cancer women with and without concomitant diabetes.
    PLoS One. 2026;21:e0319314.
    

    >> Share

    
    
39. ARCOT A, Gallagher K, Goldstein JA, Gernand AD, et al
    The relationship between maternal glucose concentrations, gestational diabetes mellitus, placental weight, and placental vascular malperfusion lesions: A retrospective study of a U.S. pregnancy cohort.
    PLoS One. 2026;21:e0325415.
    

    >> Share

    
    
40. CARSON DJ, Faasalele-Savusa K, Loia M, Tasele S, et al
    Gestational diabetes-Risk factors and outcomes among American Samoan Women (GROW): A longitudinal cohort study protocol.
    PLoS One. 2026;21:e0342061.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share